HBIO
Harvard Bioscience Inc.
$5.68
+$0.09(+1.61%)
50
Overall
60
Value
54
Tech
36
Quality
Market Cap
$22.60M
Volume
30.82K
52W Range
$2.81 - $9.46
Target Price
$60.00
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $104.5M | $77.4M | $120.8M | $116.2M | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | $86.5M | ||
| Total Revenue | $104.5M | $77.4M | $120.8M | $116.2M | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | $86.5M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-56.1M | $-38.2M | $-57.6M | $51.9M | $44.1M | $51.3M | $52.5M | $46.2M | $39.4M | $36.6M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $48.4M | $39.2M | $63.2M | $64.3M | $58.0M | $67.7M | $60.8M | $66.1M | $54.8M | $49.9M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-51.4M | $-39.8M | $-62.2M | $62.4M | $57.8M | $65.6M | $68.0M | $64.2M | $61.0M | $98.5M | ||
| Research & Development | $5.4M | $5.6M | $11.0M | $10.7M | $8.7M | $10.8M | $12.3M | $11.8M | $10.4M | $8.8M | ||
| Research Expense | $5.4M | $5.6M | $11.0M | $10.7M | $8.7M | $10.8M | $12.3M | $11.8M | $10.4M | $8.8M | ||
| Selling, General & Administrative | $41.4M | $32.6M | $45.8M | $46.0M | $43.4M | $48.9M | $49.5M | $46.8M | $43.7M | $37.0M | ||
| Selling & Marketing Expenses | $20.5M | $15.1M | $24.4M | $23.3M | $19.9M | $24.6M | $25.0M | $24.1M | $22.2M | $19.2M | ||
| General & Administrative Expenses | $20.9M | $17.5M | $21.4M | $22.8M | $23.5M | $24.3M | $24.5M | $22.8M | $21.5M | $17.7M | ||
| Salaries & Wages | $-3.5M | $-3.5M | $-3.0M | $-3.0M | $-215.0K | $349.0K | $-420.0K | $5.0M | -- | -- | ||
| Depreciation & Amortization | $2.7M | $1.6M | $5.4M | $5.7M | $5.7M | $5.8M | $6.1M | $5.5M | $5.3M | $4.0M | ||
| Depreciation & Amortization | $2.7M | $1.6M | $5.4M | $5.7M | $5.7M | $5.8M | $6.1M | $5.5M | $5.3M | $4.0M | ||
| Amortization | $2.7M | $1.6M | $5.4M | $5.7M | $5.7M | $5.8M | $6.1M | $5.5M | $5.3M | $4.0M | ||
| Other Operating Expenses | $-51.4M | $-39.8M | $-62.2M | $-2.1M | $-4.8M | $-176.0K | $-237.0K | $71.0K | $1.6M | $729.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-1.1M | $-635.0K | $984.0K | $1.9M | $221.0K | $2.1M | $-7.2M | $1.9M | $-6.2M | $-48.6M | ||
| EBITDA | $1.9M | $1.9M | $524.0K | $2.7M | $5.2M | $9.0M | $944.0K | $4.7M | $-6.1M | $-49.4M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $639.0K | $713.0K | $5.4M | -- | $4.8M | $1.5M | $2.5M | $3.6M | $3.5M | $4.9M | ||
| Interest Income Operating | $3.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Intinc | $135.0K | $-2.0M | $-5.4M | $-5.4M | $-4.8M | $-1.5M | $-2.5M | $-3.6M | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-639.0K | $-713.0K | $-5.4M | $-5.4M | $-4.8M | $-1.5M | $-2.5M | $-3.6M | $-3.5M | $-4.9M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | -- | -- | $-632.0K | $-1.6M | -- | ||
| Other Income/Expense | $-1.0M | $739.0K | $3.6M | $469.0K | $2.7M | $666.0K | $535.0K | $859.0K | $1.9M | $3.9M | ||
| Other Special Charges | $-179.0K | $-739.0K | $-3.6M | $-469.0K | $-2.7M | $-666.0K | $302.0K | $-227.0K | $-325.0K | $-3.9M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-4.0K | -- | -- | $-1.4M | $2.0M | $1.3M | $2.4M | $391.0K | -- | -- | ||
| Special Income Charges | $-672.0K | $3.6M | -- | $-1.5M | $-2.0M | $-1.3M | $233.0K | $-391.0K | $-835.0K | $-48.0M | ||
| Impairment of Capital Assets | $676.0K | -- | -- | $1.5M | -- | -- | -- | -- | -- | $48.0M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-2.4M | $-1.9M | $-8.0M | $-5.5M | $-2.5M | $1.4M | $-6.6M | $-2.6M | $-8.1M | $-52.5M | ||
| Pre-Tax Income | $-3.1M | $-2.6M | $-8.0M | $-5.5M | $-7.3M | $-140.0K | $-9.2M | $-2.6M | $-11.7M | $-57.4M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $1.2M | $-605.0K | $-3.7M | $-815.0K | $518.0K | $148.0K | $337.0K | $859.0K | $740.0K | $-686.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-1.9M | $-865.0K | $-2.9M | $-4.6M | $-7.8M | $-288.0K | $-9.5M | $-3.4M | $-12.4M | $-56.7M | ||
| Net Income (Continuing Operations) | $-1.9M | $-865.0K | $-2.9M | $-4.6M | $-7.8M | $-288.0K | $-9.5M | $-3.4M | $-12.4M | $-56.7M | ||
| Net Income (Discontinued Operations) | $-1.9M | $-865.0K | $-2.9M | $-4.6M | $-7.8M | $-288.0K | $-9.5M | $-3.4M | $-12.4M | $-56.7M | ||
| Net Income (Common Stockholders) | $-1.9M | $-865.0K | $-2.9M | $-4.6M | $-7.8M | $-288.0K | $-9.5M | $-3.4M | $-12.4M | $-56.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | $1.2M | -- | -- | -- | $-10.1M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-107.5M | $-78.0M | $-119.8M | $114.3M | $101.9M | $116.8M | $120.5M | $110.4M | $100.3M | $135.1M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $34.2M | $34.8M | $36.5M | $37.8M | $38.6M | $40.3M | $41.4M | $42.4M | $43.5M | $44.4M | ||
| Average Shares Outstanding (Diluted) | $34.2M | $34.8M | $36.5M | $37.8M | $38.6M | $40.3M | $41.4M | $42.4M | $43.5M | $44.4M | ||
| Shares Outstanding | $3.5M | $3.6M | $3.8M | $3.8M | $4.0M | $4.1M | $4.2M | $4.3M | $4.4M | $44.7M | ||
| Basic EPS | $-0.13 | $-0.02 | $-0.08 | $-0.24 | $-0.20 | $-0.01 | $-0.23 | $-0.08 | $-0.28 | $-1.28 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-0.12 | $-0.24 | $-0.20 | $-0.01 | $-0.23 | $-0.08 | $-0.28 | $-1.28 | ||
| Diluted EPS | $-0.13 | $-0.02 | $-0.08 | $-0.24 | $-0.20 | $-0.01 | $-0.23 | $-0.08 | $-0.28 | $-1.28 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-0.12 | $-0.24 | -- | -- | -- | $-0.08 | -- | -- | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | $-438.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | -- | -- | $0.04 | -- | -- | -- | -- | -- | -- | -- | ||
| Diluted Discontinuous Operations | -- | -- | $0.04 | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | $1.2M | -- | -- | $-228.0K | -- | -- | -- | $403.0K | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | $1.2M | $1.4M | -- | -- | -- | -- | -- | -- | -- | ||
| Net Income Discontinuous Operations | -- | $1.2M | $1.4M | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | $-233.0K | -- | -- | -- | ||
| Other Gand A | $20.9M | $17.5M | $21.4M | $22.8M | $23.5M | $24.3M | $24.5M | $22.8M | $21.5M | $17.7M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $-100.0K | -- | -- | -- | -- | -- | -- | ||
| Other Write Down | -- | -- | -- | -- | $787.0K | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $20.9M | $17.5M | $21.4M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $20.5M | $15.1M | $24.4M | $23.3M | -- | -- | -- | -- | -- | -- | ||
| Write Down | $484.0K | $-3.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-4.0K | -- | -- | $-1.4M | $2.0M | $1.3M | $2.4M | $391.0K | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HBIO | $5.68 | +1.6% | 30.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |